pomalidomide,atezolizumab
bms,roche
['gu ', 'atezo', 'imvigor130', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', ' pom ', ' uc,(-ucsd),(-ucsf),']
imvigor130 presented at asco gu 2023. no differences in the final os analysis of atezo vs chemo in untreated locally advanced or metastatic uc. #asco #gu23 #oncology 
A dedicated conference for oncology held under the theme "Access. Educate. Collaborate"